• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沉默抑制人宫颈癌通过 AKT 信号通路。

Silencing of inhibits human cervical cancer through the AKT signaling pathway.

机构信息

Department of Gynaecology, Ganzhou People's Hospital of Jiangxi Province, No. 18, Meiguan Avenue, Ganzhou city, 341000 Jiangxi Province China.

出版信息

Cell Mol Biol Lett. 2019 Jul 10;24:49. doi: 10.1186/s11658-019-0172-y. eCollection 2019.

DOI:10.1186/s11658-019-0172-y
PMID:31333726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6617888/
Abstract

BACKGROUND

has been demonstrated to be highly expressed in various human cancers including cervical cancer, and has been shown to play a critical role in tumor aggressiveness. We aimed to investigate the role of in human cervical cancer in vitro and in vivo.

METHOD

Reverse transcription-quantitative polymerase chain reaction assay and Western blot assay were used to detect the mRNA and protein expression, respectively. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and were performed to measure the viabilities of cancer cells. Flow cytometry assay was used to detect the cell cycle and apoptosis. Moreover, an animal experiment was performed to evaluate the biological behavior of in vivo.

RESULTS

In the current study, we found that was obviously over-expressed in cervical cancer tissues compared to the adjacent non-cancer tissues. Cervical cancer cells transfected with siRNA demonstrated significant inhibition of cancer proliferation ( < 0.01), cell cycle arrest at G0/G1 phase, and cell apoptosis ( < 0.05). Moreover, down-regulation of significantly inhibited cervical cancer growth in vivo. In addition, protein levels of , c-Myc and Cyclin D1 were much lower in the siRNA-treated groups than that in the control group.

CONCLUSIONS

inhibition reduced cervical cancer tumor growth through the AKT pathway. This effect represented a therapeutic opportunity and provided a novel target for cervical cancer treatment.

摘要

背景

已被证明在包括宫颈癌在内的多种人类癌症中高度表达,并被证明在肿瘤侵袭性中发挥关键作用。我们旨在研究在体外和体内中对人类宫颈癌的作用。

方法

逆转录定量聚合酶链反应检测和 Western blot 检测分别用于检测 mRNA 和蛋白质表达。3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法和集落形成实验用于测量癌细胞的活力。流式细胞术用于检测细胞周期和细胞凋亡。此外,进行动物实验以评估在体内的生物学行为。

结果

在本研究中,我们发现与相邻非癌组织相比,在宫颈癌组织中明显过表达。转染的宫颈癌细胞 siRNA 显示出对癌症增殖的显著抑制(<0.01),G0/G1 期细胞周期停滞和细胞凋亡(<0.05)。此外,下调显著抑制了体内宫颈癌的生长。此外,在 siRNA 处理组中的、c-Myc 和 Cyclin D1 的蛋白水平明显低于对照组。

结论

抑制通过 AKT 通路减少宫颈癌肿瘤生长。这种作用代表了一种治疗机会,并为宫颈癌治疗提供了新的靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/8dfa86594b37/11658_2019_172_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/5a4c2e393b91/11658_2019_172_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/92addf0fbb06/11658_2019_172_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/fb0f08454d2d/11658_2019_172_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/4bc32da74647/11658_2019_172_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/8dfa86594b37/11658_2019_172_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/5a4c2e393b91/11658_2019_172_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/92addf0fbb06/11658_2019_172_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/fb0f08454d2d/11658_2019_172_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/4bc32da74647/11658_2019_172_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad80/6617888/8dfa86594b37/11658_2019_172_Fig5_HTML.jpg

相似文献

1
Silencing of inhibits human cervical cancer through the AKT signaling pathway.沉默抑制人宫颈癌通过 AKT 信号通路。
Cell Mol Biol Lett. 2019 Jul 10;24:49. doi: 10.1186/s11658-019-0172-y. eCollection 2019.
2
siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.靶向SNCG基因的小干扰RNA通过下调AKT/ERK磷酸化抑制胃癌SGC7901细胞的体内外生长
Cytogenet Genome Res. 2018;154(4):209-216. doi: 10.1159/000488571. Epub 2018 Jun 15.
3
SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway.SULF2 通过 ERK/AKT 信号通路促进宫颈癌的发生发展并抑制细胞凋亡。
Braz J Med Biol Res. 2020 Feb 7;53(2):e8901. doi: 10.1590/1414-431X20198901. eCollection 2020.
4
Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.沉默 miR-202-5p 对 PIK3CA 基因表达的影响通过抑制 PI3K/Akt/mTOR 信号通路的激活对宫颈癌 SiHa 细胞的增殖、侵袭和上皮间质转化的作用。
Mol Cell Biochem. 2021 Nov;476(11):4031-4044. doi: 10.1007/s11010-021-04211-4. Epub 2021 Jul 9.
5
Tripartite motif‑containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.三结构域蛋白 14 通过 Akt 信号通路调节宫颈癌中的细胞增殖和凋亡。
Mol Med Rep. 2020 Dec;22(6):5145-5154. doi: 10.3892/mmr.2020.11634. Epub 2020 Oct 26.
6
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.唑来膦酸通过 Erk1/2 和 Akt 通路抑制宫颈癌肿瘤干细胞的干性表型,并诱导其凋亡和细胞周期停滞,从而抑制其生长。
J Exp Clin Cancer Res. 2019 Feb 21;38(1):93. doi: 10.1186/s13046-019-1109-z.
7
BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.慢病毒载体递送的 BCSG1 siRNA 抑制 MDA-MB-231 细胞的增殖和迁移。
Int J Mol Med. 2018 Mar;41(3):1659-1664. doi: 10.3892/ijmm.2017.3355. Epub 2017 Dec 29.
8
Gamma-synuclein binds to AKT and promotes cancer cell survival and proliferation.γ-突触核蛋白与AKT结合,促进癌细胞存活和增殖。
Tumour Biol. 2016 Nov;37(11):14999-15005. doi: 10.1007/s13277-016-5371-9. Epub 2016 Sep 22.
9
USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.USP18 通过激活 AKT 信号通路促进宫颈癌细胞增殖和抑制细胞凋亡。
BMC Cancer. 2020 Aug 8;20(1):741. doi: 10.1186/s12885-020-07241-1.
10
Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.hnRNP A2/B1 的敲低通过 PI3K/AKT 信号通路抑制宫颈癌细胞增殖、侵袭并触发细胞周期凋亡。
Oncol Rep. 2018 Mar;39(3):939-950. doi: 10.3892/or.2018.6195. Epub 2018 Jan 5.

引用本文的文献

1
γ-Synuclein promotes proliferation and inhibits apoptosis of oral squamous cell carcinoma via JAK2/STAT5b signaling pathway.γ-突触核蛋白通过JAK2/STAT5b信号通路促进口腔鳞状细胞癌的增殖并抑制其凋亡。
Am J Cancer Res. 2024 May 15;14(5):2408-2423. doi: 10.62347/FLIM3367. eCollection 2024.
2
The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers.微小 RNA Let-7 及其外泌体形式:妇科癌症的表观遗传调节剂。
Cell Biol Toxicol. 2024 Jun 5;40(1):42. doi: 10.1007/s10565-024-09884-3.
3
Synuclein Proteins in Cancer Development and Progression.

本文引用的文献

1
Role and Characterization of Synuclein-γ Unconventional Protein Secretion in Cancer Cells.α-突触核蛋白在癌细胞中非常规蛋白质分泌的作用及特征
Methods Mol Biol. 2016;1459:215-27. doi: 10.1007/978-1-4939-3804-9_15.
2
Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma.主要CDKN3转录本的过表达与肺腺癌患者的不良生存相关。
Br J Cancer. 2015 Dec 22;113(12):1735-43. doi: 10.1038/bjc.2015.378. Epub 2015 Nov 10.
3
siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK.
突触核蛋白在癌症发展和演进中的作用。
Biomolecules. 2023 Jun 12;13(6):980. doi: 10.3390/biom13060980.
4
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.多组学特征分析提示 PTK7 在卵巢癌 EMT 和细胞可塑性中的作用,并为治疗干预提供策略。
Cell Death Dis. 2022 Aug 17;13(8):714. doi: 10.1038/s41419-022-05161-5.
5
Upregulation of Synuclein- and Snai1 Contributes to Poor Clinical Prognosis in Oral Squamous Cell Carcinoma Patients.Synuclein 和 Snai1 的上调与口腔鳞状细胞癌患者的不良临床预后相关。
Biomed Res Int. 2022 Apr 7;2022:6534626. doi: 10.1155/2022/6534626. eCollection 2022.
6
Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.γ-突触核蛋白是一种新型的预后标志物,可促进胆管癌肿瘤细胞的迁移。
Cancer Med. 2021 Aug;10(16):5599-5613. doi: 10.1002/cam4.4121. Epub 2021 Jul 9.
7
Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth.敲除黑素瘤细胞中的α-突触核蛋白会扰乱细胞内铁代谢并抑制肿瘤生长。
Sci Rep. 2021 Mar 4;11(1):5267. doi: 10.1038/s41598-021-84443-y.
8
SOX2 Regulates lncRNA CCAT1/MicroRNA-185-3p/FOXP3 Axis to Affect the Proliferation and Self-Renewal of Cervical Cancer Stem Cells.SOX2调控lncRNA CCAT1/微小RNA-185-3p/FOXP3轴以影响宫颈癌干细胞的增殖和自我更新。
Nanoscale Res Lett. 2021 Jan 4;16(1):2. doi: 10.1186/s11671-020-03449-z.
9
The down-regulation of SNCG inhibits the proliferation and invasiveness of human bladder cancer cell line 5637 and suppresses the expression of MMP-2/9.SNCG的下调抑制人膀胱癌细胞系5637的增殖和侵袭,并抑制MMP-2/9的表达。
Int J Clin Exp Pathol. 2020 Jul 1;13(7):1873-1879. eCollection 2020.
10
SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.SNCG 通过靶向 PI3K/AKT 信号通路促进高级别浆液性卵巢癌的进展和转移。
J Exp Clin Cancer Res. 2020 May 7;39(1):79. doi: 10.1186/s13046-020-01589-9.
siRNA 介导的γ-突触核蛋白抑制通过下调 AKT 和 ERK 的磷酸化抑制 MDA-MB-231 细胞的迁移和增殖。
J Breast Cancer. 2014 Sep;17(3):200-6. doi: 10.4048/jbc.2014.17.3.200. Epub 2014 Sep 30.
4
Unconventional secretion of synuclein-γ promotes tumor cell invasion.γ-突触核蛋白的非常规分泌促进肿瘤细胞侵袭。
FEBS J. 2014 Nov;281(22):5159-71. doi: 10.1111/febs.13055. Epub 2014 Oct 10.
5
Cervix cancer brachytherapy: high dose rate.宫颈癌近距离治疗:高剂量率
Cancer Radiother. 2014 Oct;18(5-6):452-7. doi: 10.1016/j.canrad.2014.06.008. Epub 2014 Aug 21.
6
Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients.γ-突触核蛋白可预测食管癌患者的不良临床预后。
Tumour Biol. 2014 Dec;35(12):11871-7. doi: 10.1007/s13277-014-2429-4. Epub 2014 Aug 21.
7
Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption.突触核蛋白γ可保护Akt和mTOR,并使肿瘤对Hsp90破坏产生抗性。
Oncogene. 2015 Apr 30;34(18):2398-405. doi: 10.1038/onc.2014.126. Epub 2014 Jun 23.
8
Improved survival with bevacizumab in advanced cervical cancer.贝伐珠单抗治疗晚期宫颈癌可提高生存率。
N Engl J Med. 2014 Feb 20;370(8):734-43. doi: 10.1056/NEJMoa1309748.
9
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.宫颈癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii27-32. doi: 10.1093/annonc/mds268.
10
Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer.三种不同术前治疗方案在Ib2期年轻宫颈癌患者综合治疗中的价值。
Asian Pac J Cancer Prev. 2012;13(4):1487-9. doi: 10.7314/apjcp.2012.13.4.1487.